<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01747226</url>
  </required_header>
  <id_info>
    <org_study_id>GASAS-1205X</org_study_id>
    <nct_id>NCT01747226</nct_id>
  </id_info>
  <brief_title>Effect of Mouth Rinses in Oral Malodor</brief_title>
  <acronym>MR2012</acronym>
  <official_title>Masking and Therapeutic Effect of Different Mouth Rinses in Patients With Oral Malodor.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gaba International AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bad breath or halitosis is caused by specific gases originating from the mouth or the expired
      air. In most cases the pathology lies within the mouth and in this case receives the name
      pathologic halitosis of oral cause or oral malodor. The aim of this study is to evaluate the
      immediate (masking) and long term (therapeutic) effect of commercially available mouth rinses
      in the treatment of oral malodor. For this volunteers with oral malodor detected by
      organoleptic evaluation and confirmed by the increase level of sulphur compounds in their
      breath (VSC) will be asked to use a designated mouthwash. The breath parameters will be
      assessed at baseline and 15' after the first rinse (15 ml, during 1 minute) and over night at
      the end of a period of 3 weeks during which the volunteers rinsed twice a day (15 ml, 1
      minute) with the assigned mouthwash. The short and long term effect of a stannous
      fluoride/amine fluoride/zinc rinse; a chlorhexidine/cetylpyridinium chloride/zinc product and
      a negative control(fluoride rinse and/or water) will be compared.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline organoleptic score of breath (OLS)</measure>
    <time_frame>after15' and after 3 weeks</time_frame>
    <description>A trained and calibrated &quot;judge&quot; sniffs the expired air of the volunteer and assesses whether it is unpleasant by using an intensity rating, normally from 0 to 5, with 0 = no odor present, 1 = barely noticeable odor, 2 = slight but clearly noticeable odor, 3 = moderate odor, 4 = strong offensive odor, and 5 = extremely foul odor (proposed by Rosenberg and McCulloch.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in H2S and CH3SH level in breath</measure>
    <time_frame>after 15' and after 3 weeks</time_frame>
    <description>A portable gas chromatograph (OralChroma™, Abilit Corporation, Kanagawa, Japan) will be used to measures the concentration of hydrogen sulphur (H2S) and methyl mercaptan (CH3SH) in mouth air. The device has been calibrated and validated for its use by the manufacturer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline global level of volatile sulphur compounds (VSC)</measure>
    <time_frame>after 15' and after 3 weeks</time_frame>
    <description>A portable device (Halimeter®, Interscan Corporation, model RH-17E, Chatsworth, USA)able to detect sulphur compounds in air will be used according to the manufacturer instructions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline microbial load of saliva</measure>
    <time_frame>after 3 weeks</time_frame>
    <description>A sample of non-stimulated saliva will be collected into a sterile container and kept at 4°C till processing. To the standard culture of the samples (of aerobic and anaerobic incubation at 37°C) a molecular technique (qPCR)of bacterial detection will be added for periodontal pathogens (P. gingivalis, P intermedia, F. nucleatum and A. actinomycetemcomitans) and bacteria usually involved in oral malodour (S. moorei).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline microbial load of tongue coating</measure>
    <time_frame>after 3 weeks</time_frame>
    <description>Tongue coating will be collected by wiping a sterile swab 3 times over the dorsum of the tongue, in the area of the foramen caecum. Till analysis; the tip of the cotton swab will be kept in a vial containing 2ml of reduced transport fluid (RTF). To the standard culture of the samples (of aerobic and anaerobic incubation at 37°C) a molecular technique (qPCR)of bacterial detection will be added for periodontal pathogens (P. gingivalis, P intermedia, F. nucleatum and A. actinomycetemcomitans) and bacteria usually involved in oral malodour (S. moorei).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patients' opinion</measure>
    <time_frame>after 3 weeks</time_frame>
    <description>Patients' opinion regarding product satisfaction will be scored on a VAS line (0 to 10). The questionnaire will include the following points:satisfaction, side effects, use, future use and effectiveness.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Halitosis</condition>
  <arm_group>
    <arm_group_label>Fluoride rinse</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A fluoride rinse with alcohol was chosen because its similarity in color and aroma to the active rinses. This anti-cavity rinse does not contain any active components and therefore it is not expected to have any anti-malodour activity.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Halita</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Halita is a CHX-containing benchmark product that has proven to be clinically effective against halitosis (Roldan et al, 2003)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Meridol Halitosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This study aims to confirm the effect of meridol®Halitosis(AmF/SnF2 and zinc) already observed in volunteers with morning bad breath (physiological)(Wigger-Alberti et al, 2010; Wilhelm et al, 2010)in patients with oral malodor (pathological).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Water</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>To distinguish the masking effect caused by the formulations and the one caused by the rinsing itself.Only for short term evaluation (15') to not to compromise compliance of patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fluoride rinse</intervention_name>
    <description>rinse with 15 ml for 1 minute</description>
    <arm_group_label>Fluoride rinse</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Halita</intervention_name>
    <description>rinsing with 15 ml for 1 minute</description>
    <arm_group_label>Halita</arm_group_label>
    <other_name>- Halita mouthwash 500 ml. CN 323923.3</other_name>
    <other_name>- Halita, Dentaid Spain</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Meridol Halitosis</intervention_name>
    <description>rinsing with 15 ml for 1 minute</description>
    <arm_group_label>Meridol Halitosis</arm_group_label>
    <other_name>name of product meridol® HALITOSIS mouthrinse</other_name>
    <other_name>GABA product number:266831</other_name>
    <other_name>PDM number: 3*21750</other_name>
    <other_name>name of manufacturer:GABA International AG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water</intervention_name>
    <description>rinsing with 15ml for 1 minute</description>
    <arm_group_label>Water</arm_group_label>
    <other_name>bottled water</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Caucasian

          -  Age ≥ 18 years

          -  Organoleptic score of breath ≥ 2

          -  VSC readings (sum of H2S and CH3SH by OralChroma) ≥ 120 ppb*

          -  Intra-oral cause of bad breath

          -  Non-smokers

          -  Willing to participate and able to give written informed consent

        Exclusion Criteria:

          -  Ongoing dental treatment or any other medical treatment of the oral cavity

          -  Any known allergy to previously used oral hygiene products or any known allergy to any
             of the ingredients of the study products, which are used during the study

          -  Any pathological change of the oral mucosa

          -  Use of prohibited treatments / therapies and/or abuse of drugs, alcohol, etc

          -  Pregnancy or breastfeeding

          -  Active caries

          -  Acute sinusitis

          -  Severe oro-pharyngeal infections

          -  On medications which can cause malodour

          -  Reduced salivary flow due to pathological reasons (e.g. Sjögren syndrome)

          -  Situation considered not compatible with the study according to the investigator's
             opinion; the latter includes: patients eating very spicy food, persons under
             homeopathic therapy, patients who used antibiotics during the 2 months before the
             study, patients frequently using chewing gum, patients under corticosteroids or other
             serious medications.

          -  Patients unwilling to abstain from additional oral hygiene (only toothbrushing
             allowed) particularly mouthrinse, chewing gums, breath strips, etc
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Quirynen, PhD, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitarie Ziekenhuis Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc Quirynen, PhD, DDS</last_name>
    <phone>+32 16 33 24 85</phone>
    <email>marcquirynen@med.kuleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Periodontology, KULeuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jesica Dadamio, Master Bioch</last_name>
      <phone>+32 16 347282</phone>
      <email>jesica.dadamio@med.kuleuven.be</email>
    </contact>
    <investigator>
      <last_name>Jesica Dadamio, Master Bioch</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie De Geest, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc Quirynen, PhD, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Quirynen M, Dadamio J, Van den Velde S, De Smit M, Dekeyser C, Van Tornout M, Vandekerckhove B. Characteristics of 2000 patients who visited a halitosis clinic. J Clin Periodontol. 2009 Nov;36(11):970-5. doi: 10.1111/j.1600-051X.2009.01478.x. Epub 2009 Oct 6.</citation>
    <PMID>19811581</PMID>
  </reference>
  <reference>
    <citation>Wilhelm D, Gysen K, Himmelmann A, Krause C, Wilhelm KP. Short-term effect of a new mouthrinse formulation on oral malodour after single use in vivo: a comparative, randomized, single-blind, parallel-group clinical study. J Breath Res. 2010 Sep;4(3):036002. doi: 10.1088/1752-7155/4/3/036002. Epub 2010 Aug 17.</citation>
    <PMID>21383479</PMID>
  </reference>
  <reference>
    <citation>Wigger-Alberti W, Gysen K, Axmann EM, Wilhelm KP. Efficacy of a new mouthrinse formulation on the reduction of oral malodour in vivo. A randomized, double-blind, placebo-controlled, 3 week clinical study. J Breath Res. 2010 Mar;4(1):017102. doi: 10.1088/1752-7155/4/1/017102. Epub 2009 Dec 18. Erratum in: J Breath Res. 2010 Jun;4(2):029101.</citation>
    <PMID>21386207</PMID>
  </reference>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2012</study_first_submitted>
  <study_first_submitted_qc>December 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2012</study_first_posted>
  <last_update_submitted>December 10, 2012</last_update_submitted>
  <last_update_submitted_qc>December 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Marc Quirynen</investigator_full_name>
    <investigator_title>PhD DDS</investigator_title>
  </responsible_party>
  <keyword>Oral malodor</keyword>
  <keyword>Halitosis</keyword>
  <keyword>Bad Breath</keyword>
  <keyword>Mouth rinses</keyword>
  <keyword>Mouthwashes</keyword>
  <keyword>Amine fluoride/Stannous fluoride</keyword>
  <keyword>Zinc ions</keyword>
  <keyword>Chlorhexidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Halitosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorides</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

